| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | 0.048 | 0.1 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | 0.41 | 0.1 |
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.1 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | 0.047 | 0.1 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | 0.043 | 0.1 |
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | -0.1 | 0.1 |
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | 0.047 | 0.1 |
| mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | 0.055 | 0.1 |